BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34907291)

  • 1. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
    Wu X; Li W; Luo Z; Chen Y
    Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.
    Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y
    Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
    Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
    JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between FCGR2A rs1801274 and MUC5B rs35705950 variations and pneumonia susceptibility.
    Shi X; Ma Y; Li H; Yu H
    BMC Med Genet; 2020 Apr; 21(1):71. PubMed ID: 32252656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
    van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
    Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
    van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
    Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism.
    Cocconcelli E; Bernardinello N; Giraudo C; Castelli G; Greco C; Polverosi R; Saetta M; Spagnolo P; Balestro E
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
    Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
    Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Presence of T Allele (rs35705950) of the MUC5B Gene Predicts Lower Baseline Forced Vital Capacity and Its Subsequent Decline in Patients with Hypersensitivity Pneumonitis.
    Lewandowska KB; Szturmowicz M; Lechowicz U; Franczuk M; Błasińska K; Falis M; Błaszczyk K; Sobiecka M; Wyrostkiewicz D; Siemion-Szcześniak I; Bartosiewicz M; Radwan-Röhrenschef P; Roży A; Chorostowska-Wynimko J; Tomkowski WZ
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association between MUC5B Rs35705950 and Risks of Idiopathic Interstitial Pneumonia, Systemic Sclerosis Interstitial Lung Disease, and Familial Interstitial Pneumonia: A Meta-Analysis.
    Lou HQ; Huang CX; Li GY; Li P; Zhang SM; Li HG; Han L; Bao MH
    Iran J Public Health; 2020 Dec; 49(12):2240-2250. PubMed ID: 34178730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population.
    Borie R; Crestani B; Dieude P; Nunes H; Allanore Y; Kannengiesser C; Airo P; Matucci-Cerinic M; Wallaert B; Israel-Biet D; Cadranel J; Cottin V; Gazal S; Peljto AL; Varga J; Schwartz DA; Valeyre D; Grandchamp B
    PLoS One; 2013; 8(8):e70621. PubMed ID: 23940607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between complement C3 expression and the MUC5B genotype in pulmonary fibrosis.
    Okamoto T; Mathai SK; Hennessy CE; Hancock LA; Walts AD; Stefanski AL; Brown KK; Lynch DA; Cosgrove GP; Groshong SD; Cool CD; Schwarz MI; Banda NK; Thurman JM; Yang IV; Holers VM; Schwartz DA
    Am J Physiol Lung Cell Mol Physiol; 2018 Jul; 315(1):L1-L10. PubMed ID: 29565179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
    Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
    Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
    Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
    Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.